Award details

Synthesis of bryostatin scaffold molecules and studies of their interactions with protein kinase C

ReferenceB09691
Principal Investigator / Supervisor Professor Karl Joseph Hale
Co-Investigators /
Co-Supervisors
Professor Andy Gescher, Professor Gordon Roberts
Institution University College London
DepartmentChemistry
Funding typeResearch
Value (£) 258,472
StatusCompleted
TypeResearch Grant
Start date 15/09/1998
End date 31/05/2002
Duration45 months

Abstract

The ultimate aim of this project is to generate entirely novel and patentable anti- signalling drugs of potential use in the treatment of cancer. We propose to synthesise simplified analogues of the protein kinase C modulator bryostatin 1, and elucidate their mode of interaction with the enzyme to guide the synthesis of further analogues. Bryostatins, like phorbol esters, bind to cysteine-rich domains of PKC. We will define the 3D-solution structures of drug-PKC CRD complexes by high field NMR, and use this information to design other even more simplified yet highly potent PKC- modulators. These will be evaluated pharmacologically in animals in a subsequent study. Their cytostatic and cytotoxic effects in animals and cells will be determined, as will their immunostimulatory properties, and myalgic activity.

Summary

unavailable
Committee Closed Committee - Biomolecular Sciences (BMS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file